Cancer Prevention II
More than 180 participants and experts from 31 countries met for the fifth time in 10 years in St. Gallen, Switzerland for a 3-day conference to discuss important current issues of clinical cancer prevention. The meeting was again organized and co-sponsored by St. Gallen Oncology Conferences (SONK)....
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Berlin, Heidelberg :
Springer Berlin Heidelberg,
2009.
|
| Σειρά: | Recent Results in Cancer Research,
181 |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Cancer Prevention and Health Politics
- Do We Make Optimal Use of the Potential of Cancer Prevention?
- Predictors of Successful Cancer Prevention Programs
- Cancer Prevenpinon in the Developing World: Mission Impossible?
- Is Cancer Prevention Ever Going to Be Profitable?
- Cancer Prevention: The Scientific-Epidemiological Base
- Energy Metabolism, Cancer Risk, and Cancer Prevention
- Promises and Limitations of Biomarkers
- Cancer Prevention, Tobacco and Nutrition
- The EPIC Study: An Update
- Anti-angiogenic properties of Chemopreventive Drugs: Fenretinide as a Prototype.
- Retinoids and Breast Cancer Prevention
- Cancer Prevention, Genetics and Vaccines
- Cancer Prevention by Vaccination Against Hepatitis B
- Cancer Prevention and Target Organs I: Breast Cancer
- Energy Restriction for Breast Cancer Prevention
- The Use of Tamoxifen and Raloxifene for the Prevention of Breast Cancer
- Prevention of ER-Negative Breast Cancer
- EHxoorgmeonnoeuss, aMnadmEmndooggraepnhoiucs Density and Breast Cancer Risk: Can Mammographic Density Be Considered an Intermediate Marker of Risk?
- Cancer Prevention and Target Organs II: Cancer of the Digestive Tract
- Chemoprevention of Oesophageal Cancer and the AspECT Trial
- Cancer Prevention and Target Organs III: Prostate Cancer
- Review of Diagnostic Markers for Prostate Cancer 16
- Seleneium and Vitamin E Cancer Prevention Trial: A Nutrient Approach to Prostate Cancer Prevention
- Prostate Cancer Prevention by Short-Term Anti-androgens: The Rationale Behind Design of Pilot Studies
- Cancer Prevention and Target Organs III: Prostate Cancer
- Anti-angiogenic Activity of a Novel Class of Chemopreventive Compounds: Oleanic Acid Terpenoids
- Aspirin and NSAIDs in Cancer Prevention: Attempts at an International Consensus
- Pharmacologic Effects of NSAIDs and Implications for the Risks and Benefits of Long-Term Prophylactic Use of Aspirin to Prevent Cancer
- Aspirin and NSAIDs for the Prevention of Colorectal Cancer
- Aspirin and Cancer Risk: A Summary Review to 2007.
